Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2007 | 09-2007 | 06-2007 | 03-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,627 | -2,003 | -1,355 | -729 | -4,995 |
| Depreciation Amortization | 283 | 213 | 134 | 68 | 210 |
| Accounts receivable | 437 | -75 | -52 | 288 | -118 |
| Other Working Capital | 676 | -196 | -81 | 224 | -433 |
| Other Operating Activity | -116 | 351 | 289 | -260 | 1,134 |
| Operating Cash Flow | $-1,346 | $-1,710 | $-1,065 | $-410 | $-4,203 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -410 | -172 | -152 | -22 | -375 |
| Investing Cash Flow | $-410 | $-172 | $-152 | $-22 | $-375 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 1,300 |
| Debt Repayment | -52 | -34 | -21 | -10 | -38 |
| Common Stock Issued | 559 | 31 | 31 | 31 | 146 |
| Dividend Paid | -120 | -60 | -60 | N/A | -200 |
| Other Financing Activity | -93 | -90 | -60 | -30 | 7,428 |
| Financing Cash Flow | $293 | $-153 | $-110 | $-9 | $8,636 |
| Beginning Cash Position | 4,290 | 4,290 | 4,290 | 4,290 | 232 |
| End Cash Position | 2,827 | 2,255 | 2,964 | 3,849 | 4,290 |
| Net Cash Flow | $-1,463 | $-2,035 | $-1,327 | $-442 | $4,058 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,346 | -1,710 | -1,065 | -410 | -4,203 |
| Capital Expenditure | -410 | -172 | -152 | -22 | -375 |
| Free Cash Flow | -1,756 | -1,882 | -1,217 | -432 | -4,577 |